Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid (hyaluronan) is a naturally occurring glycosaminoglycan found in connective, epithelial, and neural tissues. Therapeutically, it is used as a viscoelastic agent in ophthalmology, a restorative agent in intra-articular joint injections, and a humectant in topical dermatology.
## Primary Indications
* **Ophthalmology:** Adjunct in cataract surgery, intraocular lens implantation, and corneal transplant.
* **Rheumatology:** Symptomatic relief of osteoarthritis (OA) of the knee in patients who failed conservative therapy.
* **Dermatology/Esthetics:** Correction of facial wrinkles, lip augmentation, and wound healing.
## Adult Dosing
* **Intra-articular (Knee OA):**
* *High molecular weight (e.g., Synvisc-One):* 48 mg (6 mL) injected into the knee once; repeat every 6 months if necessary.
* *Low molecular weight (e.g., Hyalgan):* 20 mg (2 mL) weekly for 5 consecutive weeks.
* **Ophthalmic:** Quantity varies by procedure; generally 0.5 mL to 1 mL into the anterior chamber during surgery.
* **Dermal Fillers:** Dose is strictly patient-specific based on site and desired correction; injected intradermally/subcutaneously.
## Pediatric Dosing
* **General:** No established systemic pediatric indications.
* **Ophthalmic:** Use is limited to specialized pediatric ophthalmic surgery; dosage is determined strictly by the surgeon based on the size of the ocular globe and the specific surgical requirements.
## Dose Adjustments
* **Renal/Hepatic:** No specific dose adjustments established; systemic absorption from intra-articular or topical use is negligible.
* **Elderly:** No adjustments required, though caution is advised regarding needle placement in patients with joint geometry alterations.
## Contraindications
* Known hypersensitivity to hyaluronan preparations.
* History of hypersensitivity to avian proteins (if the product is derived from avian sources, e.g., rooster combs).
* Presence of active joint infection (septic arthritis) or skin infections at the injection site.
## Adverse Effects
* **Intra-articular:** Transient injection site pain, joint effusion, stiffness, swelling, or arthralgia. Rarely, pseudosepsis (acute inflammatory reaction).
* **Ophthalmic:** Increased intraocular pressure (post-operatively).
* **Dermal:** Bruising, erythema, edema, itching, and rare cases of soft tissue necrosis or vascular occlusion (if injected intravascularly).
## Key Drug Interactions
* **Antiseptics:** Do not use quaternary ammonium salts (e.g., benzalkonium chloride) for skin preparation if using certain hyaluronic acid products, as they can precipitate the material.
* **General:** No significant systemic drug-drug interactions exist due to local administration.
## Monitoring
* **All:** Observe for signs of immediate hypersensitivity.
* **Intra-articular:** Monitor for severe pain or signs of joint inflammation (redness, warmth, significant swelling).
* **Ophthalmic:** Monitor intraocular pressure post-surgery.
## Clinical Pearls
* **Storage:** Most hyaluronic acid products require temperature-controlled storage; some require refrigeration. Check individual label requirements.
* **Non-equivalence:** Products are **not** interchangeable. Differences in molecular weight, cross-linking, and concentration significantly alter clinical outcomes and duration of effect.
* **Uncertainty:** For intra-articular use, clinical efficacy is controversial; verify institutional guidelines as many clinical pathways now prioritize intra-articular corticosteroids or physical therapy over viscosupplementation.
***
*Disclaimer: This information is for educational purposes only. Hyaluronic acid products vary significantly by manufacturer and specific formulation. Always consult the current product package insert, institutional pharmacy protocols, and official prescribing information before administration.*
